Resmed (RSMDF) Invested Capital (2010 - 2026)

Resmed (RSMDF) has reported Invested Capital for 17 consecutive years, with $7.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 12.92% year-over-year to $7.5 billion; the trailing twelve-month figure through Jun 2026 stood at $7.5 billion (up 12.92% YoY), and the FY2026 full-year result was $7.5 billion, up 12.92% from the prior year.
• Invested Capital advanced to $7.5 billion in Q2 2026 per RSMDF's latest filing, from $7.4 billion in the prior quarter.
• Across five years, Invested Capital topped out at $7.5 billion in Q2 2026 and bottomed at $4.0 billion in Q1 2022.
• Historically, Invested Capital has averaged $5.9 billion across 5 years, with a median of $5.7 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Invested Capital soared 44.58% in 2022, then advanced 0.0% in 2024.
• Over 5 years, Invested Capital stood at $5.5 billion in 2022, then increased by 3.06% to $5.7 billion in 2023, then climbed by 3.8% to $5.9 billion in 2024, then rose by 22.05% to $7.2 billion in 2025, then grew by 3.59% to $7.5 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $7.5 billion, $7.4 billion, and $7.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.